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Abstract 
 Large bone defects caused by trauma, disease or congenital abnormality are 
challenging clinical scenarios with limited and often inadequate solutions. Bone is a 
tissue with a remarkable capacity to regenerate given the right circumstances, but 
significantly large defects often fail to heal, as the tissues cannot span the deficiency 
at the cellular level. One approach to remedy this is to utilise tissue engineered 
constructs (TEC) to facilitate the process of bone regeneration in these large defects. 
Cell enhanced scaffolds are being explored for this purpose and determining the 
optimal cell type to combine effectively with these scaffolds is a large area of current 
research. Bone marrow derived mesenchymal stem cells have long been of interest in 
this application, as have osteoblasts, since they are primarily the cells of bone 
formation. The process of bone healing in an adult skeleton essentially echoes bone 
formation during embryogenesis and osteoblasts can originate from different 
embryological mesoderm sources. This study investigated whether this has any 
impact on the osteogenic potential, and whether cells from an immature skeleton 
compared to those from a mature skeleton show any difference in osteogenic 
potential. The bone marrow derived mesenchymal cells and osteoblasts from the 
mandible and a long bone of juvenile and adult sheep were cultured in osteogenic 
media (2D) and on polycaprolactone electrospun mesh scaffolds (3D). Juvenile 
mesenchymal cells displayed greater proliferation in conventional 2D culture 
compared to all the other cell types cultured but the adult mandibular osteoblasts had 
superior rates compared with the other cell types overall when cultured on the 
scaffolds. The findings also show the adult mesenchymal and long bone osteoblasts 
appear to have greater differentiation and osteogenesis in 2D culture compared to the 
other cell types cultured in 2D. The adult long bone osteoblasts appear to sustain 
proliferation and differentiation throughout the cultured period of 44 days. The 
findings identify there are differences in osteogenic capacity in cells with different 
embryological origin cultured in different environments, but which cell type being 
overall superior in osteogenesis is open to further clarification. Further comparison 
of the osteogenic potential in an in vivo setting would produce more specific 
information in this regard. 
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Chapter 1: Introduction/Literature review 
There exists a clinical need for alternative treatment of large bone defects 
caused by trauma, disease or congenital abnormality, other than autologous bone 
grafting. Research into cell-based therapies to determine an effectual source of bone-
forming cells for osseous regeneration is the background to the questions that were 
raised for this study. Investigating the difference in osteogenic potential of bone-
forming cells of different embryological origin will be outlined below. 
1.1 CLINICAL BACKGROUND 
Large mandibular bone defects caused by trauma, infection or tumours are 
severely disfiguring and disabling and can be a significant challenge in terms of 
surgical reconstruction especially for critical size defects. In addition to the surgical 
challenge, this class of defect cannot regenerate independently and completely 
without artificial or external manipulation or intervention. They often involve 
bicortical, or ‘through and through’ bone defects. Critical size bone defects have 
been determined across different research animal models as being the minimum sized 
intraosseous wound in a particular bone and species of animal that will not heal 
spontaneously during the lifetime of the animal, or a defect which shows less than 
ten per cent bony regeneration during the course of the animal’s life [1,2]. There are 
a number of significant factors that contribute to critical size which include age and 
species, location of defect, bone structure and vasculature, mechanical loading and 
stress, metabolic and systemic conditions, presence of periosteum and type of 
adjacent soft tissue as well as nutritional status of the animal. [1,3,4] Current gold 
standard methods of reconstruction and augmentation of bone regeneration involve 
the use of autologous bone grafting, which has a significant (20-30%) incidence of 
donor site morbidity and graft failure (over 30% complicated by non-union, fracture 
and infection). [12,13,14] This is particularly true when donor sites for bone are 
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Figure 1. Case of Autologous bone grafting after resection of large mandibular bone tumour 
A. Orthopantographic radiograph of an 83-year-old female with a large Ameloblastoma of the 
right anterior mandible. The disfiguring benign tumour had been slowly growing for years, and 
the wafer-thin outer cortex has been outlined by the red arrows. 
B. Post-operative radiograph of the above patient showing autologous Fibular bone graft fixed 
into place with titanium mandibular Trauma plates and screws. A nasogastric feeding tube, 
vessel ligation clips and skin staples can also be seen. There is radiographic artefact visible 
from the metal. 
C. Donor site morbidity was significant for this patient. The leg wound underwent dehiscence 
and infection and required return to theatre for debridement and washout. This photograph was 
taken 2 weeks after the debridement and it shows very slow wound healing and granulation. 
The patient required regular wound care, dressings and the leg was immobilised in a splint at 
all other times. She could only mobilise with assistance for 8 weeks post initial surgery. 
 
Bone is a biological tissue that has high regenerative potential however in the 
context of critical size defects, the implantation of an osteoinductive scaffold is 
essential for successful bone regeneration to occur. Such a scaffold can combine 
growth factors for osteoinduction and angiogenesis for promoting vascularisation, it 
should also allow for cell infiltration. Cells found to have great potential in the field 
of bone regeneration research are mesenchymal stem cells. These cells have been 
demonstrated to differentiate into a variety of cell lines such as osteoblasts, 
adipocytes and chondroblasts depending on the microenvironment and growth factor 
stimulus. [15,16] These cells only represent a very small fraction (0.01-0.001%) of 
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bone marrow cell population [17] with no specific surface markers however they can 
be isolated (from the mononuclear layer of bone marrow after separation by 
discontinuous gradient centrifugation).  In addition to this, there is the possibility that 
cells from bone of different embryological origin have different osteogenic potential. 
Bone will form during embryogenesis via endochondral or intramembranous 
pathways in order to generate different types of specialised bone. The craniofacial 
bones principally develop by intramembranous ossification and long bones of the 
axial skeleton form embryonically via endochondral ossification.  
1.2 RESEARCH BACKGROUND 
Due to the need clinical need regarding large bony defects and the well known 
regenerative potential of bone, the view to harness this potential has been a field of 
interest for much research. Its possible application in solving the clinical dilemma 
presented by large bone defects is of great interest to researchers and clinicians alike. 
Different strategies have been investigated in the quest for new treatment for repair 
of large segmental and critical sized bone defects, such as transplantation of cultured 
autologous cells into defect sites, or the introduction of 3-dimensional (3D) carriers 
to create mechanical stability and structure within damaged tissues. For optimal bone 
to be induced within a large bone defect, the ideal treatment solution would require 
all the key elements of the process of natural fracture healing and bone tissue 
regeneration. There are four key elements, which are osteogenic progenitor cells, 
osteoconductive matrices and osteoinductive growth factors plus a sufficient blood 
supply.  With this understanding, there has been significant investment into the 
development of improved combined cell and 3D scaffold or construct strategies.  
1.2.1 Mesenchymal Stem Cells 
There is no single consensus on what cell type is most suitable for bone 
regeneration, however the osteogenic potential of mesenchymal stem cells has been 
extensively investigated with respect to tissue engineering of bone. Bone marrow 
stromal cells and periosteal cells have also been implicated in contributing to bone 
regeneration [18] but bone marrow derived multipotent mesenchymal precursor cells 
were shown to be superior in proliferation compared to osteoblasts derived from 
tibial compact bone in sheep [16]. The significance of this may be important where 
time to populating bone scaffolds, with sufficient numbers of cells, to implantation 
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into a patient and then additionally, the rate of bone regeneration in a large defect, 
may affect the overall outcome. It was shown that the type and degree of ossification 
might be highly influenced by the origin of transplanted cells and their level of 
differentiation (Reichert et al. 2011) where osteoblasts were shown to have higher 
bone deposition with greater bone maturation than bone marrow derived 
mesenchymal cells, in vivo, when they were ectopically transplanted on scaffolds 
into mice. [19]  
 
Figure 2. Long bone development stages in the embryo (left) are echoed during bone repair in the 
adult (right). The cartilage matrix (purple) is laid down, becomes vascularised, calcified and 
eventually replaced by bone. 
 
Bone repair or regeneration following injury occurs within a defined time 
period and in an exact site and the cellular and molecular process of this repair 
essentially echoes the process of bone formation during development [20] as 
depicted in Figure 2. In the embryological development of the foetal skeleton, 
craniofacial structures derive from neural crest cells, whereas the limbs originate 
from lateral plate mesoderm. Although both forms of bone derive embryologically 
from mesenchymal origins, they undergo very different modes of ossification during 
development. Craniofacial units such as the mandible undergo rapid 
intramembranous ossification whereas long bones of limbs will develop via 
endochondral ossification during formation. In the regulation of intramembranous 
and endochondral bone formation, various Homeobox (Hox) genes (such as HoxC11, 
HoxD13, Msx-2, Cbfa1/Runx2) have been extensively studied and they encode 
highly conserved homeodomain transcription factors related to anterior-posterior axis 
patterning during embryonic development. There may be considerable redundancy 
particularly within the HoxA to D family of genes however some homeobox genes 
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have been highly conserved such as the Dlx5/6 pair, which have been linked to 
appendage development in virtually all species in which it has been identified. They 
have been shown to have a key role in the formation of the skeleton and development 
of bone. Certain Hox genes have been specifically linked to osteogenesis although 
specific roles and signalling within the complex pathways have not yet clearly been 
defined. 
1.2.2 Intramembranous Bone Formation 
Intramembranous ossification develops under the influence of bone 
morphogenetic proteins (BMPs) and also involves the activation of the transcription 
factor, core binding factor alpha 1 (CBFA1), also called runt-related gene 2 (Runx2). 
Osteoblast differentiation from neural crest derived mesenchymal cells is directly 
induced by a number of BMPs (such as BMP-2, BMP-4, BMP-7) [22], which 
activate the Cbfa1/Runx2 gene. The Cbfa1 transcription factor then also activates the 
genes for osteocalcin, an osteoblast-specific gene expressed by fully differentiated 
osteoblasts, and other bone-specific proteins of the extracellular matrix such as 
osteopontin (OPN), which are required for bone formation. Other Hox genes 
involved specifically in craniofacial development include Msx-1, Msx-2 Prx-1, Prx-
2, Barx, and Dlx5/6 genes. The expression of BMP-2 and BMP-4 is involved in 
regulating transcription factors Runx-2, Msx-1 and Msx-2 [23].  
1.2.3 Endochondral Bone Formation 
During endochondral ossification mesenchymal cell condensation precedes 
bone formation and expression of the transcription factor Sox9 is required for 
condensation. Sox9 has been shown to have a role in the suppression of late stage 
chondrogenesis by inhibiting Runx2, the main activator for differentiation of 
proliferating chondrocytes into hypertrophic chondrocytes. In order for mesenchymal 
cells to differentiate into osteoblasts during embryogenesis, three critical 
transcription factors are required: β-catenin, Runx2, Osterix (Osx) and ATF4 [24]. In 
addition to transcription factors such as Barx2 and Hox genes, several other 
molecules within the mesenchymal condensations contribute to development, such as 
growth and differentiation factor GDF5 (of the BMP family), other factors of the 
BMP, FGF and Wnt families have also been shown to be involved. In particular 
BMP2 has been shown to stimulate endochondral ossification by the regulation of 
periosteal cell fate during bone repair. This may indicate that it has a significant role 
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during the stages of early bone repair. It has been shown that BMP2 has a role in 
determining the differentiation fate of osteogenic progenitor cells towards 
chondrogenic or osteogenic cell types depending on whether the progenitors 
originated in periosteum or endosteum. [25] Figure 3 demonstrates some of the 
complex signalling pathways and transcription factors involved. [24] 
   
Figure 3. Different signalling pathways and transcription factors regulate the differentiation of 
chondrogenic and osteogenic progenitor cells during skeletal development. Early chondrogenic 
progenitor cells express BMPs, Twist1, Msx 1/2 and Sox9. Wnt/β-catenin signalling promotes pre-
osteoblast differentiation but inhibits chondrocyte differentiation. In contrast, Notch signalling, which 
is a fundamental signalling system between neighbouring cells in normal embryogenesis and tissue 
homeostasis, promotes cartilage differentiation and inhibits osteoblast differentiation. BMP is then 
required for osteocyte differentiation for final stage bone maturation. Sox 5,6 and 9 are transcription 
factors vital for chondrogenic lineage maintenance, but Runx2, Osx and ATF4 are transcription 
factors essential for osteoblast and osteocyte differentiation and maturation. Activating factors – 
green. Inhibiting factors – red. Signalling factors – blue. [24] 
  
Both intramembranous and endochondral ossification involve activation of a 
number of Hox genes by complex signalling pathways and both result in bone 
formation as an end result. However each process is significantly different, each with 
a particular number and sequence of genes involved suggesting a possible difference 
then, in osteogenic potential between the cells of craniofacial bone (neural crest cell 
origin) and that of long bone (lateral plate mesoderm origin). 
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 Leucht et al. [26] demonstrated that there exists a potential difference at the 
cellular level, between the regenerative capacities of craniofacial bone compared to 
that of long bones. It was first shown that neural crest-derived mandible, in 
transgenic mice, underwent healing by neural crest-derived skeletal stem cells and 
that mesoderm-derived tibia healed with mesoderm-derived stem cells. The stem 
cells from each lineage were then tested to investigate whether they were 
functionally interchangeable by grafting mesoderm-derived stem cells (which usually 
undergo endochondral bone formation) into mandibular defects and neural crest stem 
cells (which undergo intramembranous bone formation) into tibial bone defects. It 
was shown that in all grafts the stem cells present would differentiate into osteoblasts 
except in the case of mesoderm-derived stem cells transplanted into mandibular 
bone. These differentiated into chondrocytes and it was proposed that a mismatch 
between the Hox gene expression status of the host and donor cells could be 
responsible for this outcome in bone repair. This study was able to identify the 
mandibular skeletal progenitor cells as Hox-negative but that they adopted a HoxA-
11 positive profile when implanted into tibial defects demonstrating the great 
plasticity of these cells. The tibial skeletal progenitor cells were always Hox positive 
and remained so when implanted into Hox-negative mandibular bone. There was 
more robust in vivo bone regeneration by the neural crest-derived skeletal bone 
progenitor cells. This indicated that both osteogenic potential and proliferation have 
impact on the process of adult bone regeneration. 
 
1.3 BIOMATERIALS 
There is a discernible need for a carrier or scaffold in the transplantation of 
bone-forming cells into what would be a large, often irregularly shaped bone defect 
to provide structure microscopically, as well as macroscopically. There are many 
different types of biomaterials being investigated for their suitability as a 
biocompatible material with physical properties appropriate for bone regeneration. It 
is generally accepted that the biomaterial must be porous with macroscopic pore size 
and high interconnectivity for permitting rapid vascularisation essential for bone 
formation. The ideal structure or scaffold should be osteoconductive, potentially 
osteoinductive, possess the mechanical strength of new bone (so that it does not 
collapse under physiological mechanical loading), and be completely degraded once 
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the newly formed bone has been remodelled several times with the process of natural 
bone turnover ensuring eventual normal bone function. The manufacture of the 
scaffold material would ideally be easily reproducible and economical in cost. There 
is no single material currently available that fits all of these criteria. 
In terms of osteoconductive scaffolds for bone regeneration, the development 
of nanofiber meshes using co-electrospinning medical grade polycaprolactone (PCL) 
and collagen by the Hutmacher’s group for use in bone tissue engineering has opened 
the potential for an alternative method for regeneration of bicortical critical sized 
defects. Electrospinning has been able to produce scaffolds with determinable, highly 
uniform fiber diameter, which directly correlates to pore size of a construct. It has the 
potential to generate structures tailored for unique tissue type or defect shape and can 
reliably create 3D structures with open, interconnected pore systems essential for 
tissue ingrowth, vascularisation, nutrient and wast transport for eventual integration 
at the site of application. These are very desirable properties for a TEC, however one 
major challenge has been facilitating penetration of cells and extracellular matrix into 
the core of scaffolds. The cells cultured on electrospun fibers have been shown to 
remain largely superficially in these scaffolds. However further developments to 
overcome these challenges are being investigated. They remain a useful tool with 
great potential for investigating the nature of cell function and behaviour in a 3D 
environment, to better understand function and processes occurring in living tissue as 
a complex 3D system. [27,28] 
 
1.4 HYPOTHESIS 
My hypothesis was that osteoblasts of differing mesenchymal origin, namely 
neural crest cell embryological origin and mesodermal embryological origin, have 
different proliferation and differentiation patterns when in a 2D versus 3D culture 
environment. This may be more strongly apparent in cells isolated from juvenile 
subjects versus adult subjects so the cell types from juvenile and adult sources were 
compared. The cells used were mesenchymal stem cells and osteoblasts from the 
mandible and tibia of sheep. 
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1.5 AIMS 
The aims of this study were  
1. To isolate and characterise the chosen different cell types from 
juvenile and adult sheep and compare their proliferation and 
differentiation characteristics in 2D 
2. To isolate and characterise the chosen different cell lineage types from 
juvenile and adult sheep and compare the proliferation and 
differentiation characteristics in 3D and  
3. To compare the cell type proliferation and differentiation results 
between 2D and 3D culture environments. 
 
SUMMARY 
The main focus of this study is to explore the different osteogenic potential of 
endochondral bone origin stem cells compared to intramembranous bone origin cells 
within artificially generated bone scaffolds. Determining whether there is a 
significant advantage of one cell lineage over the other within the scaffolds in terms 
of osteogenic and osteoinductive potential may provide direction for future 
development of an alternative reconstructive substitute in the regeneration of critical 
sized bone defects of the craniofacial complex.  The following Table 1 features the 
overall design of the study. 
Table 1: Study design overview 
 Proliferation 
Assay  
ALP Assay ARS Assay PCR Assay 
2D Cell types 
compared 
Juv vs Adu Juv vs Adu Juv vs Adu - 
3D Cell types 
compared 





Juv vs Adu 
2D vs 3D 
comparison 
Pooled MSC 
vs MOB vs 
TOB 
Pooled MSC 
vs MOB vs 
TOB 
Pooled MSC 
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Chapter 2: Ovine Mesenchymal cell and 
Osteoblast isolation and 
characterisation in 2D 
This chapter outlines the methods of isolation and 2D characterisation of bone 
and marrow derived progenitor cells of juvenile and adult sheep. 
2.1 MATERIALS AND METHODS 
Cell Sources 
Two groups of merino sheep were used for isolating ovine mandibular 
osteoblasts (MOB), tibial osteoblasts (TOB) and bone marrow derived mesenchymal 
stem cells (MSC) as approved by the animal ethics committee of the Queensland 
University of Technology, Brisbane Australia (under Ethics Approval Number 
0900000099). One group consisted of juvenile sheep aged between 2-3 months and 
the other group contained adult sheep aged 6-7years. For each animal in both groups, 
we collected bone marrow aspirate, mandibular bone and tibial bone. 
Isolation of Ovine MOB, TOB 
Compact bone samples from the mandible and tibia were collected under 
general anaesthesia and sterile conditions. These were minced, washed with 
Phosphate Buffered Saline (PBS) (#18912-014, Life Technologies, one tablet in 
1000ml deionised water) and vortexed before incubation with 10ml 0.25% 
trypsin/EDTA (#25200-056, Life Technologies) for 3 minutes at 37°C, 5% CO2. The 
trypsin was inactivated using 10ml low glucose Dulbecco’s Modified Eagle Media 
(DMEM) (#11885-084, Gibco - Life Technologies) containing 10% Foetal Bovine 
Serum (FBS) (#10100-139, Life Technologies). The samples were washed once with 
PBS and transferred to 175cm
2
 tissue culture flasks (Nunc). 12ml DMEM containing 
10% FBS with 1% penicillin/streptomycin (PS) (#10378-016, Life Technologies) 
was further added to the samples. (1% PS: 100U penicillin, 100µg streptomycin 
diluted 1:100 in 10% FBS DMEM). At 5-7 days osteoblast outgrowth was observed. 
These cells were expanded to second or third and up to fourth passage for use in 
following experiments.  
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Isolation of Ovine MSC 
In order to obtain juvenile and adult ovine MSC, bone marrow aspirates were 
collected from the iliac crests of he sheep, under general anaesthesia and sterile 
conditions. The bone marrow aspirate was placed in 175cm
2
 flask and the first media 
change was performed 3 days later. This removed the non-adherent haematopoietic 
cells. The remaining cells were further cultured until confluence and subsequently 
passaged. Cells were counted using a haemocytometer and Tryptan Blue, 0.4% 
(#15250-061, Life Technologies) stained to ensure between 0.5 – 1/5 x 107 cells/ml 




 with low 
glucose DMEM containing 10% FBS and 1% penicillin/streptomycin into 175cm
2
 





. Cells of second or third passage were used for the experimental assays. 
2.1.1 Cell Proliferation Assay 
MOB, TOB and MSC at second and third passage were tripsinized and seeded 
in triplicate at 3000/cm
2
 in 24-well plates (Nunc) and cultured in 1ml low glucose 
DMEM containing 10% FBS 1% PS for 1, 3, 9, 14 days at 37°C, 5% CO2. Induction 
with osteogenic media containing dexamethasone 1µg/ml, (#D4902, Sigma-Aldrich) 
ascorbic acid 2-phosphate 1µg/ml (#A8960, Sigma-Aldrich) and β-glycerophosphate 
10nmol/ml (#G9422, Sigma-Aldrich), commenced the day after seeding. At each 
time point, cells were washed twice with PBS to remove any remaining DMEM and 
stored at -80°C. At time of analysis, the samples were thawed and digested overnight 
at 55°C in 300µL of 0.5mg/ml Proteinase K (#P6556, Sigma-Aldrich) in 1xTris-
EDTA buffer (#12090-015, Life Technologies). The cell digest was thereafter diluted 
at a ratio of 1:20 in PBE, and 100μL was aliquoted in triplicate into black 96-well 
plates, and 100µL of PicoGreen (#P11496, Life Technologies) working solution was 
added. After 5min incubation in the dark, the fluorescence (excitation 485nm, 
emission 520nm) was measured using the fluorescence plate reader (Polar Star 
Optima, BMG Labtech, Germany). A standard curve of known λ DNA 
concentrations ranging from 10ng/ml to 1µg/ml was used to calculate the final DNA 
content of the sample. 
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2.1.2 2D Differentiation in vitro 
Juvenile MSC were seeded in triplicate into 6-well plates (Nunc) and cultured 
in low glucose DMEM with 10% FBS until confluent at 8-14 days. Over the next 28 
days cells were osteogenically induced using DMEM with 10% FBS supplemented 
with 50μg/ml ascorbic acid 2-phosphate, 10mM β-glycerophosphate, 0.1μM 
dexamethasone. Standard medium, DMEM with 10%FBS was used on the control 
samples. 
2.1.3 Alkaline Phosphatase Activity 
The alkaline phosphate activity (ALP) enzyme activity was measured at days 
22 and 44 using a colorimetric assay. The sample triplicates were washed once in 
PBS, incubated with 0.1% Triton X (#X100, Sigma-Aldrich) in 0.2M Tris buffer at -
20°C for 10minutes. Harvested cells were centrifuged at 10000 rpm for 10 minutes at 
4°C. A volume of 100μL of the supernatant from the cell extractions was aliquoted to 
96-well plates (Nunc) and incubated with 125μL p-Nitrophenylphosphate (1mg/ml) 
(#N7653, Sigma-Aldrich) in 0.2M Tris buffer for 30 minutes and the optical density 
was measured at 405nm in a Polar Star Optima plate reader. The DNA content that 
was previously measured using the Quant-iT PicoGreen ds DNA assay kit (#P7589, 
Life Technologies) was used as a measure to normalise readings of the ALP activity. 
2.1.4 Alizarin Red S staining 
At day 7, 11, 14, 28, Alizarin Red S (ARS) staining was planned on both osteo-
induced and non-induced cells (n=6), however fungal infection contaminated plates 
for the juvenile cells. A remaining sample of frozen juvenile MSC, MOB, TOB were 
available and thawed and plated on 6-well plates at concentration of 3000 cells/cm
2
 
and harvested at day 14, 28. The well surface area of the 24-well plate and 6-well 




 respectively) and data was normalised 
with respect to this discrepancy. (See Figure 4 for representative set up). To harvest 
for the assay samples were washed twice in PBS, fixed with ice-cold methanol 
(#179337, Sigma-Aldrich) for 10 minutes. The cells were carefully washed with 
double-distilled water (ddH2O), excess water removed and then incubated with 1% 
Alizarin Red S (N7653 Sigma-Aldrich, 1g/100ml ddH2O pH adjusted with 
ammonium hydroxide), pH 4.1 for 10 minutes with gentle agitation of the plates. 
Excess dye was removed and the cells carefully washed 3 times with ddH2O. After 
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air-drying, semi-quantification of the mineralisation was performed by dissolving the 
ARS in 800µL of 10% (v/v) acetic acid (A6283, Sigma-Aldrich, 1ml glacial acetic 
acid diluted with 9ml ddH2O). Each well was gently shaken for 30 minutes at room 
temperature. The cell monolayer was removed with a cell scraper and the resulting 
suspension was transferred to 1.5ml microcentrifuge tubes and individually vortexed 
for 30 seconds. 500μL of mineral oil (#330779, Sigma-Aldrich) was added to each 
tube and heated to 85°C for 10 minutes then cooled on ice for 5 minutes. The 
samples were centrifuged at 10000rpm for 15 minutes at 4°C and 500μL of this 
supernatant was then transferred to 1.5ml microcentrifuge tubes. To neutralise the 
acid, 200μL of 10% (v/v) ammonium hydroxide (#320145, Sigma-Aldrich) was 
added to each tube. Then 150μL of the supernatant of each triplicate sample was read 
at λ = 405mn in 96-well microtiter plates (Polar Star Optima plate reader, BMG 
Labtech, Offenberg Germany). The DNA content of separate samples was used to 
normalise the quantified staining as the acetic acid treatment was expected to 
denature the DNA of the samples. 
   
   
Figure 4. Experimental set up for ARS staining. Fungal infection decimated the number of plates 
available for culture and harvest. MSC, MOB and TOB were osteogenically induced. The control 
wells were maintained with regular media. Representative examples of the day 14, 28 ARS stained 6-
well plates show cell layer detachment and pellet formation. 
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2.1.5 Statistical Analysis 
This was performed using a one-way ANOVA and p values < 0.05 were taken 
to be significant. 
 
2.2 RESULTS 
2.2.1 Proliferation Assay in 2D 
Cell proliferation was shown to be greatest in the MSC cell lines of both 
juvenile and adult sheep when compared with the respective juvenile MOB, TOB 
and adult MOB, TOB.  Proliferation was comparable between the juvenile and adult 
MOB and TOB cell types over 14 days of culture. See Figure 5. 
 
Figure 5. Proliferation assay in 2D comparing juvenile and adult MSC, MOB and TOB over 14 days 
 
PicoGreen assay on juvenile MSC induced in osteogenic media compared with 
MSC cultured in normal media showed the differentiated MSC responded with 
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Figure 6. Differentiation assay in 2D on MSC cultured in osteogenic media compared with control 
MSC cultured in normal media over 28 days. 
2.2.2 ALP Assay in 2D 
Measured ALP activity was compared across the three cell types MSC, MOB 
and TOB. The results showed ALP activity detected was highest overall in the 
juvenile MOB and comparable between the juvenile MSC, TOB and adult MSC, 
MOB, TOB.  
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2.2.3 ARS Assay in 2D 
The ARS quantification showed increased calcium production by cells induced 
in osteogenic media compared to MOBs in normal, which were used as control cells. 
In the pooled cell types the TOB appeared to have the highest rate of calcium 
production of the three in this 2D study. At day 28 the osteogenically induced MSC, 
MOB and TOB demonstrated a sharp decline in calcium production. See Figure 8. 
 
Figure 8. ARS staining results on combined juvenile and adult MSC, MOB, TOB results. MOB 
cultured in normal media were used as a control. 
 
In further analysis of the data, comparison was made between juvenile and 
adult MSC in order to see if there was a difference within this group (see Figure 9). 
The proliferation assay showed the MSC had the greatest initial proliferation, which 
then proceeded to taper over the time cultured. The results of the juvenile and adult 
MSC comparison show little difference. The juvenile MSC level of mineralisation 
did not seem to change between day 14 and 28. The adult MSC matrix mineralisation 
initially appeared greater than the juvenile MSC mineralisation but not significantly 
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Figure 9. Comparison of ARS staining results on juvenile MSC and adult MSC cultured over 28 days 
 
2.3 DISCUSSION 
The cell layer detachment from the bottom of the wells was a persistently 
observed phenomenon. It was considered that poor cell layer adherence might have 
been due to the type of plates used to culture the cells but this was seen to occur 
more consistently with the longer the cells were cultured. The formation of cell 
pellets with a cell monolayer detachment was an initial concern as it could be 
considered that the rate of proliferation within the pellet would be different to the 
monolayer. With the Alizarin Red staining, there might have been loss of cells or cell 
pellets even with careful washing technique, which contributed to increased variation 
in measurements. 
Proliferation in 2D 
In comparing the three cell types overall, it could be interpreted that the 
juvenile and adult MSC appeared to have the greatest proliferation of the three cell 
types over 14 days. With osteoinduction the MSC also appear to show greater 
proliferation compared to MSC not osteogenically induced. Factors that may need to 
be considered include the cell detachment and cell pellet formation that seemed to 
occur across all the cultured plates. Whether this was due to the plates, the passage 
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Interestingly it has been shown that in vitro monolayer culture of human 
primary osteoblasts often display limited ECM deposition, maturation and 
calcification. Jähn et al. (2010) investigated cell pellet culture versus monolayer 
culture of primary osteoblasts over 7 days and discovered a pellet could decrease 
initial proliferation and increase transformation of the osteoblasts into a more mature 
phenotype. Increased proliferation was absent in the pellet cultures and the cells 
having rapidly undergone cell maturation explained this. [29] 
ALP Assay in 2D 
As a marker of osteogenic differentiation the assay results showed that apart 
from slightly superior ALP activity in the juvenile MOB, there was no marked 
difference in the ALP activity across the juvenile MSC, TOB and adult MSC, MOB 
and TOB cell lines by Day 44. This does not echo the results from the proliferation 
assay where it would be expected that with MSC osteoinduction, a rise in ALP would 
be demonstrable and that even the MOB and TOB would show some upward trend in 
ALP activity.  
The study on pellet culture of human osteoblasts, showed the expression 
pattern of phenotype markers (Runx2, Osx and osteocalcin) differed across low-
density seeded monolayer, high-density monolayer and pellets of osteoblasts, with 
the pellets showing transformation the furthest along the osteoblast phenotype. [29] 
This altered differentiation pattern was proposed to occur due to the 3D 
microenvironment of the cell pellet and not due to cues from mineralised matrix. 
Given that cell pellet formation occurred with the extended cultures to 22 and 44 
days it could be that the cells may have reached a more mature phenotype.  
ARS Assay in 2D 
The results of the ARS assay for the pooled cell types did suggest a progression 
of osteoblast maturation with increasing matrix mineralisation over time however it 
was noted the MSC population did not produce significantly greater mineralisation 
activity by day 28. The proliferation results though, had pointed to juvenile and adult 
MSC demonstrating greater activity compared with the other cell types at day 14 of 
culture. As a result, the MSC cell line was selected for further analysis to assess the 
potential difference between the juvenile and adult cells (see Figure 9). However, 
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this actually did not demonstrate a significant difference between the juvenile and 
adult cells at 14 and 28 days. 
The limitation of ARS staining is that it is a semi-quantification assay that aims 
at detection of elements of macroscopic cell differentiation. These elements such as 
mineralised matrix or enzyme production, being measurable quantities that may be 
highly variable depending on the means and methods of assay. The standard assay 
protocol was accurately followed, exactly as directed in order to maintain 
reproducibility in the results. However technical factors such as degree of turbulent 
or insufficiently vigorous rinsing are difficult to correct for and this may be a 
contributing factor in the variation observed in the results. The alternative would be 
to investigate levels of gene expression within the cells and this has greater relevance 
in the 3D environment, which is discussed in Chapter 3. 
2.4 CONCLUSION 
The observed results indicate cell proliferation over 14 days was highest in 
MSC which could be expected as these cells would be differentiating under the 
influence of osteogenic media. The ALP activity over 44 days did not significantly 
differ across the three cell types and this could be attributed to transformation of 
osteoblasts to more mature osteoblast phenotype in the MOB and TOB and 
differentiation and cell phenotype maturation of the MSC by day 22. After which, 
further differentiation may have slowed to a steady state. The ARS staining did not 
provide as much useful information as matrix mineralisation measured only slightly 
higher in juvenile MOB and remained comparable across all the other cell types, 
both juvenile and adult. The formation of cell pellets from initial monolayer cell 
culture, which has been shown to alter the proliferation and differentiation profile of 
the cultured cells, and additional technical factors may be a contributing factor in 
these results. 
2.5 SUMMARY AND IMPLICATIONS 
The implications of these findings suggest that limiting time of culture may 
produce clearer trends. Comparisons with gene expression could produce more 
information on the state of cell maturation during stages of proliferation and 
differentiation across the three cell types. Quantification of calcium deposition and 
correlation with different states of cell maturation could indicate which cell type may 
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be superior in terms of osteogenesis, for mass culture in 2D and subsequent use for 
bone regeneration purposes. 
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Chapter 3: (3D in Vitro Study) 
Cells in living tissue and organs exist, interact and function in 3 dimensions. 
Modelling this environment may provide better understanding of the complex signals 
and processes that occur in osteogenesis with the eventual aim of directing or 
enhancing bone regeneration and repair in clinical practice. 
Electrospun polycaprolactone (PCL) meshes were used as the scaffold to 
investigate if a difference in osteogenic capacity could be observed in MSC, MOB 
and TOB in a 3D culture platform compared to a 2D culture environment. 
3.1 METHODOLOGY AND RESEARCH DESIGN 
3.1.1 Mesh Fabrication 
This was established by polymer melt electrospinning of medical grade PCL as 
per protocol outlined in the paper – Hutmacher, Dalton et al. [26,30] to produce disc 
shaped meshes with pore size range 350-500µm. The process involves driving 
molten PCL to a thermal head which is positioned above an x-y collector tray, A 
high electrical voltage is then applied between the thermal head and the collecting 
stage with temperatures applied by the thermal head in the range of 90-120°C. The 
meshes are generated with reliable accuracy in filament diameters depending on the 
flow rate and spinneret diameter used. The scaffold structure can also be manipulated 
by moving the x-y stage but also by varying the voltage, which affects the arc of the 
molten PCL flow.  
The selection of meshes was made based on weight in order to obtain as 
homogenous a scaffold template as possible across each experiment, with diameter 
of 5.5 - 6.5mm. See Figure 10. 
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Figure 10. Example of a PCL electrospun mesh. Gross overview (left panel), scanning 
electron micrograph (right panel). 
 
 Mesh treatment – Meshes were immersed in 1M sodium hydroxide (NaOH) 
for 4 hours at 37°C. They were washed in ddH2O 5 times and stored in 70% ethanol 
until time of use. One day prior to seeding the 70% ethanol was changed and meshes 
immersed for 3 hours in 70% ethanol and then placed on sterile well plates in a Class 
2 Biosafety cabinet overnight for evaporation. UV light sterilisation was also done 
prior to seeding for 1 hour with turning over of the meshes with sterile forceps after 
30min irradiation. 
3.1.2 Proliferation on Meshes 
Prepared meshes were seeded with adult and juvenile MSC, MOB and TOB at 
a concentration of 50,000 cells/20µl. Each mesh received 20µl in 24-well plates 
(Nunc) and incubated for cell adherence at 37°C, 5% CO2 for 75min. A further 1ml 
of DMEM with 10% FBS and 1%PS was added to each well and incubated at 37°C 
5%CO2. Osteogenic media was then used from the following day and meshes were 
transferred to 15ml Falcon tubes to exclude cell adherence to well surfaces of culture 
plates. Meshes were harvested at day 1, 11, 22, 33, 44. 
3.1.3 ALP measured from the media 
The proliferation meshes were utilised for this assay on the media so the time 
points of day 11, 22, 33, 44 are the same. One day prior to mesh harvest, the meshes 
were transferred from 15ml falcon tubes to 24 well plates and washed with Phenol 
Red-free and FBS-free media (#11054-020, Life Technologies) until no visible 
colour was observed (5-10min). Then 1ml of Phenol Red-free and FBS-free media 
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was added to each mesh and incubated for 24 hours at 37°C. ALP activity was 
measured using the SigmaFAST
TM
 kit (#N1891, Sigma-Aldrich), as per the 
manufacturer’s instructions. 100 µL of p-Nitrophenylphosphate in Tris-base buffer 
was added to 100 µL of the culture media in a 96-well plate, and incubated at 37°C 
and 5% CO2 for another 24 hours. At the end of the second incubation period, the 
plate was brought back to ambient temperature (20°C) for 5 min and the absorbance 
was read at 405 nm using a plate reader (Benchmark Plus
TM
 microplate 
spectrophotometer, BIO RAD). The ALP absorbance was normalised by the DNA 
content of each sample. 
3.1.4 ARS Assay on Meshes 
Modified procedure for ARS dye extraction from cell-seeded meshes was 
developed by Sascha Zaiss and implemented by both him and myself. Cell lines used 
were the same ovine juvenile and adult MSC, MOB and TOB. 
After day 22 and 44, cultured meshes were treated as per the usual monolayer 
ARS staining protocol. Meshes (n=3) without cells but placed in media for 22 and 44 
days were stained and used as controls. Dye extraction and quantification proceeded 
with transferring stained meshes to tubes and storage at -20°C until all samples were 
ready for dye extraction and quantification. 500µL of 10% w/v acetic acid was added 
to each tube with the meshes and incubated at room temperature for 2-3 hours. 
Samples were vortexed for 10-15min until the red colour had disappeared. 200μL of 
mineral oil was added to each Eppendorf tube and the samples were then heated to 
85°C for 10min. Samples were immediately transferred to ice for 10min and then 
centrifuged at 20,000g for 15min. 300μL of the sample was transferred to new 
Eppendorf tubes and 120μl of 10% ammonium hydroxide was added to each new 
tube to neutralise the acid. 150µL of each sample (in triplicate) was transferred to a 
transparent 96 well microtiter plate and read at λ = 405nm (Polar Star Optima Plate 
Reader, BMG Labtech, Offenburg Germany). 
3.1.5 PCR Assay on cells from the Meshes 
RNA isolation and purification methods: 
Samples for time points of day 0, 22, 44 were washed twice with PBS until 
phenol red was no longer visible. The meshes were transferred to 1.7ml Eppendorf 
tubes and vortexed at 500rpm for 1min at room temperature to remove excess fluid, 
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which was then extracted by pipette. TRIzol® (1ml) (#15596-026, Life 
Technologies) was added to the scaffolds and vortexed for 15sec then incubated for 
5min at room temperature. Chloroform (300µl) (#C2432, Sigma-Aldrich) was added 
to each tube and shaken vigorously for 15sec and incubated for 3min at room 
temperature. The tubes were centrifuged at 10,000rpm for 15min at 4ºC. 
For RNA purification the upper aqueous phase containing the RNA was 
transferred to new RNA free 1.7ml Eppendorf tubes. RNA was separated using 
750µl isopropanol (#I9516, Sigma-Aldrich), tubes were mix-inverted 5 times and 
incubated for 10min at room temperature then centrifuged at 10,000rpm for 10min at 
4ºC. The supernatant was carefully removed by pipette, and the RNA pellet was 
allowed to air dry for 10min at room temperature. The pellet was resuspended in 
20µl RNAse free water and concentration of RNA was measured with NanoDrop 
ND-1000 spectrophotometer. Further purification of RNA samples was performed 
using 3M sodium acetate (#S7899, Sigma-Aldrich) treated with Diethyl 
pyrocarbonate -DEPC (0.1% w/v) (#D5758, Sigma-Aldrich) to degrade any possible 
contaminant RNAses. The existing samples in 20µl RNAse free water (#AM9935, 
Life Technologies) were placed in new Eppendorf tubes with 40µl RNAse free 
water, 5µL 3M sodium acetate, 130µl of 100% ethanol (molecular biology grade) 
(#E7023, Sigma-Aldrich) and stored at -20ºC overnight. Samples were spun at 
14,000rpm for 1 hour at 4ºC the next day and the supernatant removed. The RNA 
was washed with 200µl 75% ethanol (molecular biology grade, diluted with RNAse 
free water) and spun at 7,500rpm for 10min at 4ºC. The supernatant was removed 
and the RNA pellet was allowed to air dry at room temperature for 10min before 
resuspension in 15µl RNAse free water and the concentration was read on the 
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Primers were ordered from GeneWorks Pty Ltd. 
RT-PCR protocol:  
Reverse transcriptase performed as per DyNAmo cDNA Synthesis Kit (#F-
470L, Finnzymes Oy). The cDNA samples were stored at -20ºC until Real Time 




3.2.1 Proliferation on meshes 
Sascha Zaiss conducted much of this work with adult and juvenile ovine MSC, 
MOB and TOB cell lines. Time points selected for harvesting cells were Day 0,11, 
22, 33 and 44. The following graph, Figure 11, shows his results comparing the 
juvenile MSC, MOB, TOB versus the adult cell types over the course of 44 days. 
The graph indicates that the most proliferation occurred in the juvenile and adult 
MOB. 
Proliferation trended upward for all the cell types and the juvenile MSC, TOB 
and adult MSC, TOB had comparable levels of proliferation over 44 days of culture. 
 
Figure 11. Proliferation assay results comparing juvenile and adult MSC, MOB and TOB cultured 
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3.2.2 ALP out of the media 
Sascha Zaiss quantified the ALP activity out of the media the meshes were 
cultured in at day 11, 22, 33 and day 44. The results of the juvenile MSC, TOB and 
MOB were compared with the adult MSC, TOB and MOB first. Figure 12 shows 
there was higher initial osteogenic differentiation observed with the juvenile MSC 
compared to all the other cell types but this rate declined by day 44. The juvenile 
MOB and TOB appeared to maintain a steady level of ALP activity that was still 
higher than any of the adult cell types.  The Adult FOB (Fibula Osteoblast – 
equivalent to Tibia as skeletal long bones) had the highest ALP activity of the adult 
cell types but was still inferior to the juvenile MOB and TOB cell ALP activity. A 
relative downward trend after initial high ALP activity at the first time point, day 11, 
was observed across the subsequent time points for juvenile MOB, TOB and adult 
MOB.  
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3.2.3 ARS – meshes 
Due to processing technical issues, results were only obtained for meshes 
cultured to day 44. For illustration purposes a stained mesh and control mesh are 
presented in Figure 13. 
 
Figure 13. A. Day 44 ARS stained Mesh with adult TOB at x10 magnification. B Day 44 unseeded 
control mesh x10 magnification. Sascha Zaiss, 2010. Digital photomicrograph.   
 
 The graph shows that the most calcium deposition was seen in the juvenile 
MSC and secondarily in the adult MSC. The other cell types displayed little ARS 
staining. See Figure 14. 
 
Figure 14. ARS staining assay comparing juvenile and adult MSC, MOB and TOB at day 44 of 
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3.2.4 PCR 
The genes selected for assay have been shown to be involved with osteoblast 
differentiation and function. The chosen genes have different roles in the 
proliferation and differentiation pathway, which is of interest in demonstrating which 
cell types express which genes at differing times during the culture process.  
The gene and the expressed protein function with respect to proliferation and 
osteogenesis will be very briefly outlined here. 
Potentially expressed more strongly during cell proliferation and initiation of cell 
differentiation (See Figure 15) 
 BMP2 – protein induces bone and cartilage formation and belongs to the 
TGF-β superfamily of regulatory proteins. It promotes the differentiation of 
chondrocytes and regulates osteoblast differentiation as well as activating 
Sox-9. [31, 34] 
 SMAD1-5 – protein activates BMP2 and is expressed where BMP signalling 
occurs as it is essential for BMP signal transduction [34]. 
• WWTR1 or TAZ – regulates SMAD accumulation within the cell nucleus 
and is expressed with cell proliferation. The protein regulates embryonic stem 
cell self-renewal, promotes cell proliferation and epithelial-mesenchymal 
transition 
 TGFB3 - expression is related to early bone and cartilage formation and is 
highly influenced by BMP, SMAD, CITED2. WWTR1 is a regulatory protein 
for SMAD and SMAD has direct influence on BMP and TGF-β [34,35,40] 
 
Potentially expressed more during early differentiation (See Figure 16) 
 CITED2 – regulates TGF-β signalling by interacting with SMAD-2, 3. The 
expression of this gene and WWTR1, SMAD and BMP are markers for 
differentiation [35]. 
 CTNNB1 encodes the β-1 Catenin protein (Cadherin-associated protein) 
which is linked with the Wnt signalling pathway that is involved early in 
osteoblast differentiation 
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 The MSX-1 protein is essential in mediating inductive interactions and for 
normal craniofacial, limb and ectodermal organ morphogenesis. [32,38] 
Potentially may show higher expression around or during active bone formation (See 
Figure 17) 
 CCDC80 is expressed after osteoblast differentiation occurs and then is down 
regulated after this [36]. 
 MSX-2 is a Hox gene and is expressed with active bone formation and 
morphogenesis and is influenced by FGFr3 [37,39]. 
 
Potentially more noticeably expressed at the mature osteoblast phenotype stage of 
differentiation – during bone remodelling (See Figure 18) 
 Osteopontin (OPN) and FGF2 are expressed with remodelling of bone and 
are linked to mature osteoblasts or osteocytes and osteoclasts. [33] 
 
 
Figure 15. Relative gene expression of BMP-2, TGFB3, SMAD1-5, WWTR1 - These genes could be 
proposed to be used as markers for the proliferation and early differentiation stages during culture of 
osteoprogenitor and osteogenic cells. 
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 The relative expression of BMP-2 closely follows a similar pattern obtained 
for the SMAD-5 gene expression (and the WWRT-1) across all the different 
cell types. This would be consistent with the functional relationships between 
the three genes. (WWRT-1 regulates the nuclear accumulation of SMAD-5, 
which in turn activates BMP-2) 
• The relative gene expression of TGFB3 across the cell types again follows 
the pattern of expression of WWRT-1, SMAD1-5, BMP-2  
• The SMAD 1-5 graph shows greater relative expression in all Adult cell types 
over Juvenile cell types for D11 and D44 but mixed result in D22 where 
Juvenile MSC showed greater relative expression compared to MOB and 
TOB 
• The WW RT1 protein regulates the nuclear accumulation of SMADs and has 
a key role in coupling them to the transcriptional machinery. The graph 
shows its relative gene expression to be highest in adult TOB and then adult 
MSC.   
 
Figure 16. Relative gene expression of CITED2, CTNNB1, MSX1 - These genes may be suggested as 
markers in early differentiation 
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• CITED2 interacts with SMAD-2 and SMAD-3, which may explain its pattern 
of expression across the samples – it is similar to the SMAD1-5 and TGFB3 
expression graphs. 
• The CTNNB1 gene encodes the protein β-1 Catenin, which is a key 
downstream component of the canonical Wnt signaling pathway (involved in 
body axis specification, morphogenic signaling). Its expression across all cell 
types in both Adult and Juvenile samples is consistent with it being in effect a 
housekeeping gene. 
• The graph for MSX-1 shows a significantly greater relative gene expression 
in the MOBs of both Juvenile and Adult cell types, but also the Juvenile TOB 
but minor expression in comparison with the MSC cell types of both sources 
 
Figure 17. Relative gene expression of CCDC80, MSX2, FGFr2 - These genes as potential markers of 
active bone formation stage 
 
• The pattern of its expression of CCDC80 in the tested cell samples show 
greater expression in MSC and TOB cell lines, and better expression in Adult 
MSCs and TOBs compared to Juvenile cell lines 
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• The relative gene expression of MSX-2 across the cell types has a pattern 
similar to that of BMP-2, and to a lesser extent TGFB3 
• The pattern of relative gene expression of FGFr2 shown in the graph is 
difficult to interpret. There is less expression in both the Adult and Juvenile 
MOBs compared to the other cell types overall. 
 
 
Figure 18. Relative gene expression of OPN, FGF2 - These genes viewed as expressed markers in 
mature bone formation or remodelling 
 
• The graph for OPN shows greatest relative expression in Juvenile MOBs at 
day 11 and day 22.  
• The relative gene expression of FGF2 across the samples tested appeared 
only significantly raised in Adult TOBs compared to the other cell types 
 
3.3 2D VERSUS 3D ASSAY COMPARISONS 
The comparison of the assay results in 2D compared to 3D could only be based 
on the trends seen over the time cultured. In some instances the time points between 
2D and 3D studies did not match. This is accounted for due to technical difficulties 
including loss of certain time point samples due to fungal infection of culture plates 
and assay processing technical issues, in particular the ARS staining. 
 
Proliferation comparison 
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The closest available time points were selected for comparison between the 2D 
and 3D assays although for the 3D assay cells were cultured to 44 days. The results 
show that in the 2D environment, MSC had the overall highest proliferation 
compared to the MOB and TOB. However in the 3D environment over a similar 
duration of culture, the MOB showed greater proliferation compared to the MSC and 
TOB. See Figure 19. 
 
 
Figure 19. Pooled MSC, MOB, TOB proliferation assay results in 2D and 3D. The time points for the 
2D study did not match the time points for the 3D study however the closest available data was 
selected for comparison. 
 
ALP assay comparison 
The results showed that in 2D there was slightly greater ALP expression by 
MOB over the MSC and TOB. However in 3D there was no significant difference 
between the cell types in their ALP production over the time cultured. 
 
 
Figure 20. Pooled MSC, MOB, TOB ALP assay results in 2D and 3D. 
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ARS quantification comparison 
There results here were most affected by the technical processing difficulties 
encountered during culture and staining. The available pooled results in 2D showed 
that the TOB had the highest calcium deposition by day 14 of culture compared to 
the MSC and MOB but all three cell types showed a significant decline at day 28 
which was the last time point available for that assay. The 3D study only yielded 
day44 results, which showed the MSC had greater calcium deposition compared to 
the MOB and TOB. 
 
 




The 3D proliferation study demonstrated that juvenile and adult MOB had the 
highest overall proliferation levels compared with the other cell types. There was 
clearly a steady increase in proliferation activity charted over the whole 44 days of 
culture. In comparison, the 2D study showed the highest proliferation activity in the 
juvenile and adult MSC populations with ongoing increase in proliferation over the 
14 days of culture. The 2D juvenile and adult MOB trend in proliferation showed no 
indication that given any longer culture would have resulted in their proliferation 
rates taking over the juvenile and adult MSC proliferation. This generates the 
question of whether the 2D culture favours MSC proliferation and 3D environment 
triggers greater proliferation in MOB populations. 
With regard to osteogenic differentiation, the 2D ALP assays showed only 
slightly greater differentiation levels in the juvenile MOB whereas in 3D there was 
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initially higher ALP activity juvenile MSC but this declined by day 44 of culture. In 
the other cell types, juvenile MOB, TOB and adult TOB showed comparable ALP 
activity over the same period and the lowest activity was seen in the adult MSC and 
MOB populations. It would be expected that the greatest proliferation and 
differentiation would be most likely to occur in the MSC and that once cells had 
committed to differentiation then proliferation would halt or decline. This pattern of 
differentiation is somewhat evident in the 3D juvenile MSC ALP levels however in 
the 2D proliferation assay, the level of proliferation appears to continue in the 
juvenile MSC and not plateau or decline.  
The 3D ARS results showed the most mineralisation occurred in the juvenile 
and adult MSC at day 44 compared to the other cell types. This would also seem to 
support that osteogenic differentiation was ongoing in this cell population at day 44 
of culture. It could be proposed that the MSC may have a self renewing sub-
population of cells that continue to proliferate as those cells that commit to 
differentiation continue to mature in phenotype. The 3D environment may trigger or 
allow this process to occur whereas the 2D environment may be less permissive of 
free inductive interactions and signalling between cells. This may partly explain the 
marked drop in detected mineralisation in the 2D ARS assay from day14 to day 28 
across all the pooled cell types. 
The PCR results have some elements to also support ongoing proliferation 
within certain cell populations despite obvious differentiation. However interpreting 
the results is slightly more complex given that the genes selected are not wholly 
specific to bone formation and many have multiple functions as well as being 
expressed in multiple different tissue types. Based on known functions the genes 
were hypothetically grouped to make trends, or patterns of expression, across the 
different cell samples potentially more clear.  
Due to the regulatory nature of WWTR1 on SMAD and then SMAD’s 
activation of BMP the gene expression pattern was very similar. BMP, SMAD and 
CITED2 also have regulatory influences on TGFB3 and so its expression also echoed 
the other graphs. Where they were being expressed most strongly was in the adult 
TOB with initial high expression then down trend by day 44. The second cell type to 
show milder elevated expression of these genes was the adult MSC with increasing 
levels over the 44 days. BMP2 both acts on TGFB and regulates osteoblast 
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differentiation whereas TGFB3 has roles in stimulating osteoblast bone formation, 
proliferation and differentiation in committed osteoblasts. This could explain the 
pattern of higher expression in the adult TOBs and to a lesser extent adult MSC. 
Interestingly there was no marked increase in relative expression in the juvenile 
MSC, MOB, TOB or adult MOB. 
CTNNB1 expression was highest in the adult TOB and its expression increased 
over the 44 days of culture but was only marginally higher than the other cell types. 
It encodes a key protein involved in Wnt signalling which is pervasive throughout a 
great variety of cells. MSX-1 showed higher expression levels in the juvenile and 
adult MOB, which may reflect on its role in craniofacial development, 
embryogenesis and cell differentiation. The expression was high initially then 
declined in the juvenile MOB but for the adult MOB there was a peak at day 22. A 
smaller day 22 peak was also noted in the juvenile TOB. The juvenile and adult MSC 
did not show elevated expression of MSX-1 though. It could be considered that 
MSX-1 may have somehow been reactivated in cells originating from craniofacial 
bone within the 3D culture environment by factors undeterminable by the scope of 
this study. 
CCDC80 gene expression was notable in the adult MSC and TOB with rising 
levels, and is expressed by differentiating osteoblasts but then down regulated after 
differentiation. This suggests that the adult MSC and TOB had sustained osteoblast 
differentiation over the 44 days of culture, compared to the other cell types. However 
the protein also has a role in extracellular matrix assembly, which could partly 
explain its continued expression in adult TOB. Reichert et al (2011) [19] were able to 
show that ovine cortical osteoblasts outperformed bone marrow derived MSC on 
scaffolds in vivo. The reasons for this involve multiple other factors, one of which 
was BMP7, which was not assayed for in this study. It should be remembered that 
even with careful design and planning, in vitro tests do not necessarily translate to 
the same outcomes of in vivo results.  
MSX-2 was expected to have high expression levels where active bone 
formation was predicted. It seemed to have increasing expression in adult MSC over 
the period of culture and after an initial peak in the adult TOB, exhibited a decline in 
expression. FGFr2 expression had upward trending levels in juvenile and adult MSC 
and the adult TOB. It showed initial high expression in the juvenile TOB but then 
 Chapter 3: (3D in Vitro Study) 39 
declined by day 44. It is expressed during bone growth during embryonic 
development and later on, in both endochondral and intramembranous ossification 
however showed very little expression in juvenile or adult MOB. 
OPN and FGF2 were expected to show expression in cells with advanced 
osteoblast phenotype. They did initially peak in adult TOB and then declined in 
expression. The OPN showed peaks at day 22 in juvenile and adult MOB. The PCR 
results generate more questions for future investigation to better understand the 
processes involved and to determine how to manipulate the processes involved in 
order to enhance bone regeneration. 
3.5 CONCLUSION 
The aims of this study were to compare the proliferation and differentiation 
profiles of adult and juvenile ovine mesenchymal stem cells and osteoblasts from 
different embryological origin in a 2D environment and a 3D environment. The 
results in 2D culture were compared between juvenile and adult cell types and found 
the juvenile MSC displayed measured proliferation rates higher than the juvenile 
MOB and TOB and adult MSC showed the same trend, but there was no stand out 
cell type for differentiation in the comparison across juvenile and adult cell types.  
In a 3D environment comparison between juvenile cell types and adult cell 
types, proliferation was shown to be the strongest in the juvenile and adult MOB. In 
the 3D differentiation assay, the juvenile and adult MSC seemed to be superior. 
There may have been technical factors and difficulties contributing to the 2D 
differentiation assay showing little variance between cell types in this respect. The 
findings seem to indicate that within these groups of cells there is continued 
proliferation and differentiation in sub-populations that persist over an extended 
period of culture and that 3D environment may play a significant factor in the 
behaviour of the cells.  
The investigation of specific gene expression in cells cultured in 3D produced 
results that also support the fact that proliferation persists within the population of 
cells despite confirmed commitment to osteoblastic phenotype and maturation of 
these cells. The results leave the way open for further research into gene expression 
comparison between 2D cultured cells and 3D cultured cells to determine how best to 
utilise the osteogenic cells and facilitate more efficient bone regeneration. 
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In conclusion, the results show there are differences in the proliferation and 
differentiation of cells cultured in a monolayer versus a 3D scaffold. The differences 
being that MSC show stronger proliferation characteristics in 2D culture whereas 
cells in 3D culture demonstrated greater levels of measurable differentiation. Even 
so, within both culture mediums, it was observed that both proliferation and 
differentiation was sustained over an extended period of culture indicating multiple 
influences are at play within the cell populations and the environment they are 
cultured in.  
3.6 SUMMARY 
In summary, there appear to be a difference in cell behaviour in the process of 
osteogenesis in ovine MSC, MOB, and TOB when cultured in 2D versus 3D 
environments. This difference being, greater levels of proliferation in both the adult 
and juvenile MSC in 2D culture compared to the other cell types in 2D, and greater 
proliferation of juvenile and adult MOB in 3D culture when compared with the other 
cell types in 3D. Adult MSC and TOB showed greater differentiation rates in 2D 
culture compared to the other cell types in 2D and the adult TOB displayed sustained 
proliferation and differentiation throughout the period of experimental culture in 3D 
compared to the other cells in 3D. 
 
3.7 FUTURE DIRECTIONS 
This study generates the question of how might the results differ in vivo and 
what other factors could stimulate proliferation and differentiation at a controllable 
and predictable rate. This could be used in creating viable cell seeded tissue 
constructs for implantation into an animal model with view to developing a clinically 
applicable alternative for large bone defects. 
 Bibliography 41 
Bibliography 
1. Cacchioli A, Spaggiari B, Ravanetti F, Martini FM, Borghetti P, Gabbi C. 
The critical sized bone defect: morphological study of bone healing. Ann Fac 
Medic Vet di Parma 2006;26:97-110. 
2. Spicer PP, Kretlow JD, Young S, Jansen JA, Kasper FK, Mikos AG. 
Evaluation of bone regeneration using the rat critical size calvarial defect. Nat 
Protocols 2012 (7):1918-1929. 
3. Gugala Z, Gogolewski S. Healing of critical-size segmental bone defects in 
the sheep tibiae using bioresorbable polylactide membranes. Injury 2002;33 
Suppl 2:B71-76. 
4. Oest ME, Dupont KM, Kong HJ, Mooney DJ, Guldberg RE. Quantitative 
assessment of scaffold and growth factor-mediated repair of critically sized 
bone defects. J Orthop Res 2007;25(7):941-950. 
5. Gugala Z, Lindsey RW, Gogolewski S. New Approaches in the Treatment of 
Critical-Size Segmental Defects in Long Bones. Macromol Symp 
2007;253:147-161. 
6. Rimondini L, Nicoli-Aldini N, Fini M, Guzzardella G, Tschon M, Giardino 
R. In vivo experimental study on bone regeneration in critical bone defects 
using an injectable biodegradable PLA/PGA copolymer. Oral Surg Oral Med 
Oral Pathol Oral Radiol Endod. 2005;99(2):148-154. 
7. Pluhar GE, Turner AS, Pierce AR, Toth CA, Wheeler DL. A comparison of 
two biomaterial carriers for osteogenic protein-1 (BMP-7) in an ovine critical 
defect model. J Bone Joint Surg Br 2006;88(7):960-966. 
8. Schlegel KA, Lange FJ, Donath K, Kulow JT, Wiltfang J. The monocortical 
critical size bone defect as an alternative experimental model in testing bone 
substitute materials. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 
2006;102(1):7-13. 
9. Borsch C, Melsen B, Vargervik K. Importance of the critical-size bone defect 
in testing bone-regenerating materials. J Craniofac Surg 1998 9(4):310-6. 
 42 Bibliography 
10. Khaltaev N, Pfleger B, Woolf AD, Mathers C, Akesson K, Hazes JM, 
Symmons D. Assessing the burden of musculoskeletal conditions: a joint 
World Health Organisation-Bone and Joint Decade project. Arthritis Res 
Ther. 2003; 5(Suppl 3);174. 
11. Cancedda R, Giannoni P, Mastrogiacomo M. A tissue engineering approach 
to bone repair in large animal models and in clinical practice. Biomaterials. 
2007;28(29):4240-50. 
12. Sorger JI, Hornicek FJ, Zavatta M, Menzner JP, Gebhardt MC, Tomford 
WW, et al. Allograft fractures revisited. Clin Orthop Relat Res. 
2001;(382):66-74. 
13. Schwartz CE, Martha JF, Kowalski P, Wang DA, Bode R, Li L, et al. 
Prospective evaluation of chronic pain associated with posterior autologous 
iliac crest bone graft harvest and its effect on postoperative outcome. Health 
Qual Life Outcomes. 2009;7(49) 
14. Mankin HJ, Hornicek FJ, Raskin KA. Infection in massive bone allografts. 
Clin Orthop Relat Res. 2005;(432):210-6. 
15. Pountos I, Corscadden D, Emery P, Giannoudis PV. Mesenchymal stem cell 
tissue engineering: Techniques for isolation, expansion and application. 
Injury. 2007;38(4):S23-S33. 
16. Reichert JC, Woodruff MA, Friis T, Quent VM, Gronthos S, Duda GN, 
Schütz MA, Hutmacher DW. Ovine bone- and marrow-derived progenitor 
cells and their potential for scaffold-based bone tissue engineering 
applications in vitro and in vivo. J Tissue Eng Regen Med. 2010;4(7):565-76. 
17. Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P, Ma K, Zhou C. Comparative 
Analysis of Mesenchymal Stem Cells from Bone Marrow, Cartilage, and 
Adipose Tissue. Stem Cells Dev. 2008;17:761-774. 
18. Miura M, Miura Y, Sonoyama W, Yamaza T, Gronthos S, Shi S. Bone 
Marrow Derived Stem Cells for Regenerative Medicine in Craniofacial 
region. Oral Dis. 2006;12:514-522. 
 Bibliography 43 
19. Reichert JC, Quent VM, Nöth U, Hutmacher DW. Ovine Cortical Osteoblasts 
Outperform Bone Marrow Cells in an Ectopic Bone Assay. J Tissue Eng 
Regen Med. 2011;5(10):831-44. 
20. Gersh RP, Lombardo F, McGovern SC, Hadjiargyrou M. Reactivation of Hox 
gene expression during bone regeneration. J Orthop Res. 2005;23(4):882-90. 
21. Chae SW, Jee BK, Lee JY, Han CW, Jeon YW, Lim Y, Lee KH, Rha HK, 
Chae GT. HOX gene analysis in the osteogenic differentiation of human 
mesenchymal stem cells. Genet Mol Biol. 2008;31(4):815-823. 
22. Qi H, Aguiar DJ, Williams SM, La Pean A, Pan W, Verfaillie CM. 
Identification of genes responsible for osteoblast differentiation from human 
mesodermal progenitor cells. PNAS. Mar 2003;100(6):3305-3310. 
23. Doshi RR, Patil AS. A Role of Genes in Craniofacial Growth. IIOABJ. 
2012;3(2):19-36. 
24. Wirrig EE, Yutzey KE. Developmental Pathways in CAVD, Calcific Aortic 
Valve Disease, Dr E Aikawa (Ed.), Chapter 3 (2013). ISBN: 978-953-51-
1150-4, InTech, DOI: 10.5772/54356. Available from: 
http://www.intechopen.com/books/calcific-aortic-valve-
disease/developmental-pathways-in-cavd 
25. Yu YY, Lieu S, Lu C, Colnot C. Bone morphogenetic protein 2 stimulates 
endochondral ossification by regulating periosteal cell fate during bone 
repair. Bone. 2010;47(1):65-73. 
26. Leucht P, Kim JB, Amasha R, James AW, Girod S, Helms JA. Embryonic 
origin and Hox status determine progenitor cell fate during adult bone 
regeneration. Development. 2008;135:2845-2854. 
27. Hutmacher DW, Dalton PD. Melt Electrospinning. Chem Asian J. 2011;6:44-
56. 
28. Reichert JC, Duda GN, Hutmacher DW, Epari DR, Wulschleger ME, 
Saifzadeh S, Steck R, Schütz MA, Lienau J, Sommerville S, Dickinson IC. 
Establishment of a pre-clinical ovine model for tibial segment bone defect 
repair by applying bone tissue engineering strategies. Tissue Eng. 
2010;16(1):93-104. 
 44 Bibliography 
29. Jähn K, Richards RG, Archer CW, Stoddart MJ. Pellet Culture Model for 
Human Primary Osteoblasts. Eur Cell Mater. 2010;20:149-16. 
30. Brown TD, Dalton PD, Hutmacher DW. Direct Writing By Way of Melt 
Electrospinning. Adv Mater. 2011;20:1-7. 
31. Chen D, Zhao M, Mundy GR. Bone Morphogenetic Proteins. Growth Factors 
2004;20(4):233-241. 
32. Alappat S, Zhang ZY, Chen YP. MSX Homeobox Gene Family and 
Craniofacial Development. Cell Res. 2003;13:429-442. 
33. Sodek J, Gauss B, McKee MD. Osteopontin. Crit Rev Oral Biol Med. 
2000;11(3):279-303. 
34. GeneCards (2011) Bone Morphogenetic Protein 2 [online] available at URL 
http://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP2 [accessed August 
2011] 
35. GeneCards (2011) Cbp/P300-Interacting Transactivator, With Glu/Asp-Rich 
Carboxy-Terminal… [online] available at URL 
http://www.genecards.org/cgi-bin/carddisp.pl?gene=CITED2&search=cited2 
[accessed August 2011] 
36. GeneCards (2011) Coiled-Coil Domain Containing 80 [online] available at 
URL http://www.genecards.org/cgi-
bin/carddisp.pl?gene=CCDC80&search=ccdc80 [accessed August 2011] 
37. GeneCards (2011) Fibroblast Growth Factor Receptor 2 [online] available at 
URL http://www.genecards.org/cgi-
bin/carddisp.pl?gene=FGFR2&search=fgfr2 [accessed August 2011] 
38. GeneCards (2011) Msh Homeobox 1 [online] available at URL 
http://www.genecards.org/cgi-bin/carddisp.pl?gene=MSX1&search=msx1 
[accessed August 2011] 
39. GeneCards (2011) Msh Homeobox 2 [online] available at URL 
http://www.genecards.org/cgi-bin/carddisp.pl?gene=MSX2&search=msx2 
[accessed August 2011] 
40. GeneCards (2011) Transcription Growth Factor Beta 3 [online] available at 
URL http://www.genecards.org/cgi-
bin/carddisp.pl?gene=TGFB3&search=tgfb3 [accessed August 2011]  
